News
DHR-PRB
1261.26
0.00%
0.00
BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks
Reuters · 12/17 15:40
BUZZ-U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas Roadhouse
Reuters · 12/17 14:14
Danaher Corporation Schedules Fourth Quarter Earnings Conference Call
Reuters · 12/17 12:30
BUZZ-Jefferies updates ratings on life sciences firms for 2026
Reuters · 12/17 12:02
U.S. RESEARCH ROUNDUP-Airbnb, Garrett Motion, Range Resources
Reuters · 12/17 07:13
Liberty All-Star Growth Fund Inc. Reports November 2025 Portfolio Update
Reuters · 12/15 20:01
DANAHER CORP <DHR.N>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $265 FROM $250
Reuters · 12/15 12:18
DANAHER CORPORATION <DHR.N>: WELLS FARGO RAISES TARGET PRICE TO $240 FROM $230
Reuters · 12/15 11:22
U.S. RESEARCH ROUNDUP-Applied Materials, Coca-Cola, Glacier Bancorp
Reuters · 12/15 08:11
Danaher Corporation announces $0.32 quarterly dividend
Reuters · 12/09 21:15
Danaher Summit Showcases AI Breakthroughs in Life Sciences
Reuters · 12/02 14:15
DANAHER CORPORATION <DHR.N> : HSBC RAISES TARGET PRICE TO $270 FROM $255
Reuters · 12/01 06:19
Mitchell P. Rales Reports Sale of Danaher Corporation Common Shares
Reuters · 11/26 21:31
Danaher Director Teri List Reports Disposal of Common Shares
Reuters · 11/19 22:00
Danaher CFO Matthew McGrew Reports Sale of Common Shares
Reuters · 11/13 22:01
Danaher SVP Brian W. Ellis Reports Disposal of Common Shares
Reuters · 11/13 22:01
Danaher Chairman Mitchell P. Rales Reports Sale of Common Shares
Reuters · 11/13 21:30
Danaher SVP Human Resources Georgeann Couchara Reports Disposal of Common Shares
Reuters · 11/12 22:01
Danaher CEO to Present at Jefferies Global Healthcare Conference
Reuters · 11/11 21:15
Danaher Chairman Mitchell P. Rales Reports Sale of Common Shares
Reuters · 11/04 21:31
More
Webull provides a variety of real-time DHR-PRB stock news. You can receive the latest news about Danaher Corp through multiple platforms. This information may help you make smarter investment decisions.
About DHR-PRB
Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s segments include Biotechnology, which includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services; Life Sciences segment, which offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics segment that offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease, and Environmental & Applied Solutions segment, which offers products and services that help protect precious resources and keep global food and water supplies safe.